当前位置:首页 - 行情中心 - 华兰疫苗(301207) - 财务分析

华兰疫苗

(301207)

  

流通市值:23.24亿  总市值:98.63亿
流通股本:1.42亿   总股本:6.01亿

华兰疫苗(301207)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至2025年第一季度实现净利润0.33亿元,每股收益0.06元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至2025年第一季度最新股东权益604771.78万元,未分配利润232506.22万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至2025年第一季度最新总资产744315.87万元,负债139544.09万元。

利润表
报告期2025-03-312024-12-312024-09-302024-06-30
营业总收入24,282,534.721,127,812,323.85957,363,018.6235,528,955.73
营业总成本49,573,022.32961,283,918.27757,727,172.19122,298,010.07
营业利润36,468,293.21214,856,027.17305,871,419.424,580,784.19
利润总额35,337,733.22214,545,726.25305,901,098.1625,158,114.96
净利润32,777,072.14205,515,315.75267,359,727.8625,274,437.06
其他综合收益----
综合收益总额32,777,072.14205,515,315.75267,359,727.8625,274,437.06
资产负债表
报告期2025-03-312024-12-312024-09-302024-06-30
流动资产合计5,058,482,095.794,976,519,526.94,631,880,229.624,443,507,039.34
非流动资产合计2,384,676,612.062,546,736,316.683,009,768,553.082,815,619,415.63
资产总计7,443,158,707.857,523,255,843.587,641,648,782.77,259,126,454.97
流动负债合计1,352,185,166.851,464,122,765.11,503,316,976.561,300,678,930.61
非流动负债合计43,255,764.3145,988,556.5844,150,617.7942,910,217.22
负债合计1,395,440,931.161,510,111,321.681,547,467,594.351,343,589,147.83
归属于母公司股东权益合计6,047,717,776.696,013,144,521.96,094,181,188.355,915,537,307.14
股东权益合计6,047,717,776.696,013,144,521.96,094,181,188.355,915,537,307.14
负债和股东权益合计7,443,158,707.857,523,255,843.587,641,648,782.77,259,126,454.97
现金流量表
报告期2025-03-312024-12-312024-09-302024-06-30
经营活动现金流入小计224,237,741.751,832,965,932.341,314,347,439.35934,433,491.79
经营活动现金流出小计226,825,367.561,364,924,489.86963,702,883.75684,113,860.25
经营活动产生的现金流量净额-2,587,625.81468,041,442.48350,644,555.6250,319,631.54
投资活动现金流入小计3,485,674,379.619,428,608,927.2714,744,165,919.049,631,318,720.99
投资活动现金流出小计3,585,330,704.9819,489,688,786.1914,777,971,609.278,903,103,771.04
投资活动产生的现金流量净额-99,656,325.38-61,079,858.92-33,805,690.23728,214,949.95
筹资活动现金流入小计-16,281,00016,281,00016,281,000
筹资活动现金流出小计30,660,000.01441,103,352.53442,826,685.86373,253,697.51
筹资活动产生的现金流量净额-30,660,000.01-424,822,352.53-426,545,685.86-356,972,697.51
汇率变动对现金及现金等价物的影响55,928.01-84,323.07-22,088.97-48,570.33
现金及现金等价物净增加额-132,848,023.19-17,945,092.04-109,728,909.46621,513,313.65
期末现金及现金等价物余额490,186,996.72623,035,019.91531,251,202.491,262,493,425.6
最新报告期:2025-03-30
研究机构分析师预测每股收益(元)更新日
2025年2026年2027年
华泰证券代雯,张云逸1.071.411.772025-03-30
TOP↑